<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01533545</url>
  </required_header>
  <id_info>
    <org_study_id>H-3-2011-154</org_study_id>
    <secondary_id>2012-000948-98</secondary_id>
    <nct_id>NCT01533545</nct_id>
  </id_info>
  <brief_title>Effect of Epinephrine on Systemic Absorption of Mepivacaine in Uremic Patients</brief_title>
  <official_title>Effect of Epinephrine on Systemic Absorption of Mepivacaine Administered for Brachial Plexus Block in Patients With Chronic Renal Insufficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine the effect of epinephrine on systemic absorption of
      local anaesthetic mepivacaine administered for brachial plexus block in uremic patients
      scheduled for creation or repair of an arteriovenous fistula. Furthermore, an impact of
      epinephrine on the central circulation and peripheral tissue oxygenation will be evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Slow recruitment
  </why_stopped>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma concentration of mepivacaine</measure>
    <time_frame>0, 5, 10, 20, 30, 45, 60, 120, and 180 min after blockade</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Central circulation</measure>
    <time_frame>0, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, and 60 min after blockade</time_frame>
    <description>Heart rate, blood pressure, cardiac output, stroke volume, and systemic vascular resistance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral tissue oxygenation</measure>
    <time_frame>0, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, and 60 min after blockade</time_frame>
    <description>Near infrared spectrometry obtained from the triceps muscle of the blocked arm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiotoxicity of local anesthetic</measure>
    <time_frame>0, 5, 10, 20, 30, 45, and 60 min after blockade</time_frame>
    <description>12-lead ECG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurotoxicity of local anesthetic</measure>
    <time_frame>Continuously for 1 hour after blockade</time_frame>
    <description>Visual and hearing disturbances, dysarthria, tingling, perioral numbness, dizziness, paraesthesia, muscular twitching and rigidity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Renal Insufficiency, Chronic</condition>
  <arm_group>
    <arm_group_label>Plain mepivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Mepivacaine with epinephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mepivacaine with epinephrine</intervention_name>
    <description>Ultrasound-guided infraclavicular brachial plexus block with mepivacaine 400 mg (10 mg/mL) mixed with epinephrine 200 μg (5 μg/mL)</description>
    <arm_group_label>Mepivacaine with epinephrine</arm_group_label>
    <other_name>Carbocain-Adrenalin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Plain mepivacaine</intervention_name>
    <description>Ultrasound-guided infraclavicular brachial plexus block with plain mepivacaine 400 mg (10 mg/mL)</description>
    <arm_group_label>Plain mepivacaine</arm_group_label>
    <other_name>Carbocain</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient acceptance of regional anaesthesia

        Exclusion Criteria:

          -  peripheral arteriosclerosis

          -  diabetes mellitus

          -  bleeding disorder

          -  infection at the puncture site

          -  allergy to mepivacaine

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robertas Martusevicius, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>McEllistrem RF, Schell J, O'Malley K, O'Toole D, Cunningham AJ. Interscalene brachial plexus blockade with lidocaine in chronic renal failure--a pharmacokinetic study. Can J Anaesth. 1989 Jan;36(1):59-63.</citation>
    <PMID>2914337</PMID>
  </reference>
  <reference>
    <citation>Norio K, Mäkisalo H, Isoniemi H, Groop PH, Pere P, Lindgren L. Are diabetic patients in danger at renal transplantation? An invasive perioperative study. Eur J Anaesthesiol. 2000 Dec;17(12):729-36.</citation>
    <PMID>11122310</PMID>
  </reference>
  <reference>
    <citation>Niemi G. Advantages and disadvantages of adrenaline in regional anaesthesia. Best Pract Res Clin Anaesthesiol. 2005 Jun;19(2):229-45. Review.</citation>
    <PMID>15966495</PMID>
  </reference>
  <reference>
    <citation>Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med. 2004 Nov-Dec;29(6):564-75; discussion 524. Review.</citation>
    <PMID>15635516</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2012</study_first_submitted>
  <study_first_submitted_qc>February 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2012</study_first_posted>
  <last_update_submitted>April 15, 2014</last_update_submitted>
  <last_update_submitted_qc>April 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Robertas Martusevicius</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Mepivacaine</keyword>
  <keyword>Epinephrine</keyword>
  <keyword>Brachial plexus block</keyword>
  <keyword>Renal insufficiency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Mepivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

